# Xihua University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/xihua-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 76.3 |
| Citations | 424,630 |
| City | Chengdu |
| Country | CN |
| Description | Xihua University is a research organisation in Chengdu, CN. OpenAlex records 17,649 works and 424,630 citations for it. 7,534 researchers list it as their most recent affiliation. |
| Homepage | https://www.xhu.edu.cn |
| OpenAlex ID | https://openalex.org/I102345215 |
| Researchers | 7,534 |
| ROR ID | https://ror.org/04gwtvf26 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q8044421 |
| Works | 17,649 |

## University papers

Showing 12 of 95.

- [Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma](https://scholariq.org/papers/gefitinib-or-carboplatin-paclitaxel-in-pulmonary-adenocarcinoma/)
- [The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer](https://scholariq.org/papers/the-iaslc-lung-cancer-staging-project-proposals-for-revision-of-the-tnm-stage/)
- [Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study](https://scholariq.org/papers/erlotinib-versus-chemotherapy-as-first-line-treatment-for-patients-with-advanced/)
- [Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer](https://scholariq.org/papers/crizotinib-versus-chemotherapy-in-advanced-i-alk-i-positive-lung-cancer/)
- [Lung cancer: current therapies and new targeted treatments](https://scholariq.org/papers/lung-cancer-current-therapies-and-new-targeted-treatments/)
- [Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-versus-chemotherapy-for-previously-untreated-pd-l1-expressing/)
- [Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer](https://scholariq.org/papers/osimertinib-or-platinum-pemetrexed-in-i-egfr-i-t790m-positive-lung-cancer/)
- [First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer](https://scholariq.org/papers/first-line-crizotinib-versus-chemotherapy-in-i-alk-i-positive-lung-cancer/)
- [Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial](https://scholariq.org/papers/afatinib-versus-cisplatin-plus-gemcitabine-for-first-line-treatment-of-asian/)
- [Perovskite light-emitting diodes based on spontaneously formed submicrometre-scale structures](https://scholariq.org/papers/perovskite-light-emitting-diodes-based-on-spontaneously-formed-submicrometre/)
- [Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer](https://scholariq.org/papers/osimertinib-in-resected-i-egfr-i-mutated-non-small-cell-lung-cancer/)
- [Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)](https://scholariq.org/papers/biomarker-analyses-and-final-overall-survival-results-from-a-phase-iii/)

## University researchers

- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)
- [Yang Liao](https://scholariq.org/researchers/yang-liao/)
- [Yuexin Zhang](https://scholariq.org/researchers/yuexin-zhang/)

## University top topics

Showing 8 of 24.

- [Cavitation Phenomena in Pumps](https://scholariq.org/topics/cavitation-phenomena-in-pumps/)
- [Hydraulic and Pneumatic Systems](https://scholariq.org/topics/hydraulic-and-pneumatic-systems/)
- [Industrial Technology and Control Systems](https://scholariq.org/topics/industrial-technology-and-control-systems/)
- [Advanced Sensor and Control Systems](https://scholariq.org/topics/advanced-sensor-and-control-systems/)
- [Advanced Algorithms and Applications](https://scholariq.org/topics/advanced-algorithms-and-applications/)
- [Advanced Computational Techniques and Applications](https://scholariq.org/topics/advanced-computational-techniques-and-applications/)
- [Simulation and Modeling Applications](https://scholariq.org/topics/simulation-and-modeling-applications/)
- [Advanced biosensing and bioanalysis techniques](https://scholariq.org/topics/advanced-biosensing-and-bioanalysis-techniques/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.